???pagination.result.count???
???pagination.result.page???
1
Molecular determinants of multiple effects of nickel on NMDA receptor channels. , Gavazzo P., Neurotox Res. January 1, 2009; 15 (1): 38-48.
Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor. , Masuko T., Neurochem Int. January 1, 2007; 50 (2): 443-9.
Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)- en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride). , Sun L., J Pharmacol Exp Ther. August 1, 2004; 310 (2): 563-70.
Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist. , Gill R., J Pharmacol Exp Ther. September 1, 2002; 302 (3): 940-8.
Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/ NR2A receptors. , Low CM., Proc Natl Acad Sci U S A. September 26, 2000; 97 (20): 11062-7.
In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. , White HS., J Pharmacol Exp Ther. January 1, 2000; 292 (1): 425-32.
Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists. , Tamiz AP., J Med Chem. August 26, 1999; 42 (17): 3412-20.